LSV Asset Management
BIVV

LSV Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

LSV Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,350
Closed -$558K – 1015
2017
Q4 		$558K Sell
10,350
-1,300
-11% -$71.1K ﹤0.01% 847
2017
Q3 		$664K Buy
11,650
+5,140
+79% +$301K ﹤0.01% 842
2017
Q2 		$391K Sell
6,510
-9,274
-59% -$528K ﹤0.01% 879
2017
Q1 		$859K Buy
+15,784
New +$777K ﹤0.01% 815

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

LSV Asset Management's BIVV Position: Q1 2018 in Review

LSV Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 10,350 shares — an estimated $558K sold.

LSV Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $859K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • LSV Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • LSV Asset Management sold 10,350 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $558K.
  • LSV Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • LSV Asset Management's Bioverativ Inc. Common Stock position peaked at $859K in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on LSV Asset Management's 13F filing for Q1 2018, filed 4 May 2018.